Menu

Katie Kazem

Associate

I love working with companies as they grow – learning about the work they do and getting to know the people who turn great ideas into reality.

kkazem@cooley.com

Katie Kazem's practice focuses on corporate and securities law and includes the general representation of both public and private companies, with particular experience in advising European life sciences companies on IPOs, capital raising, SEC compliance and corporate governance. She has experience working on M&A, public offerings and venture capital financings.

Download full bio 

Experience

  • MaxCyte – $202 Million IPO 

  • AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value 

  • Landos Biopharma – $100 Million IPO 

  • Nanobiotix – $113 Million IPO 

  • AppHarvest to Combine With Novus Capital, a Special Purpose Acquisition Company 

  • View all

Passions

    Painting

    Reading

    Running

Education

  • George Mason University, Antonin Scalia Law School
    JD, magna cum laude, 2010

  • George Mason University, School of Public Policy
    MA, 2007

  • College of William & Mary
    BA, Government
    Monroe Scholar, 2003


Admissions & Credentials

Virginia

District of Columbia